BRR
I have seen estimated price models of between $63,000 and $70,000 bandied about for Cvac, but of course it's too early to expect a firm price.
As you say, it's important for PRR management to ensure their marketing and reimbursement model is more robust than DNDN's has been. I would imagine if they had not already done so, this experience will make it a high priority for them.
They don't need to announce what their program will actually be (that would be commercial in confidence info), just that they are planning a different marketing strategy than the one DNDN has employed. That would restore a modicum of confidence.
BRRI have seen estimated price models of between $63,000 and...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 41.0¢ | 38.5¢ | $1.351M | 3.389M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16911 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 154170 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |